Nevertheless, for breast carcinoma, as well as for other non-prostatic tumors, more evidences are needed to definitively collocate this approach in the diagnostic workup, and most important, other studies should investigate the possible application of 177Lu-PSMA RLT. Here, FOLH1 is linked to prostate neoplasm.